key: cord-1043200-4rlrfvc9
authors: Moreno-Galarraga, Laura; Taveras, Elsie M.
title: COVID-19 disease in children: not as mild as we have been led to believe
date: 2020-06-23
journal: World J Pediatr
DOI: 10.1007/s12519-020-00380-2
sha: c4cab10b08fdf60b4791ccb5e0830fefde4c1df4
doc_id: 1043200
cord_uid: 4rlrfvc9

nan

Since severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged, we have followed this pandemic with great interest and concern from Europe (Navarra-Spain) and the United States (Boston-Massachusetts). We were expecting children to present to emergency departments with the "classical COVID-19 symptoms-triad" such as fever, cough, and a range of respiratory distress [1] and we had learned from countries affected earlier by the virus, that it appeared to be less common and relatively mild in children [2, 3] .

However, in April 2020, pediatricians from different Europeans countries and the United States began reporting cases of COVID-19 in children, requiring intensive care unit treatment and associating severe cardiac-symptoms, generally presenting 3-5 weeks after the COVID-19 peak. We have learned how children can present with a wide range of clinical symptoms, with respiratory symptoms not always being present and how some previously healthy children can present with skin-lesions, hypotension and tachycardia developing in the next hours an acute cardiac failure (with elevated cardiac-enzymes and imagine-compatible findings with acute-myocarditis).

As more case-reports and publications emerge in the next months, with different countries reporting their cases, we expect to learn more about this severe pediatric presentation, also referred as "Kawasaki-like" or "pediatric inflammatory multisystem syndrome". We believe it is related to coronavirus but it seems to affect in a late phase of the disease [many cases report negative polymerase chain reaction (PCR) but positive immunoglobulin G], therefore, it might be related to a systemic inflammatory response or a delayed immune response. Pediatricians should be aware of this uncommon but possible complication, tachycardia and hypotension should be used as early red-flags, and SARS-CoV-2 should be suspected even if PCR is negative.

Many questions still need answers, but if this new pediatric presentation is related to COVID-19, it deserves fast and deeper investigation. The association between pediatricsevere-cardiac-cases and SARS-CoV-2 needs to be demonstrated and best prevention strategies, red flags, diagnosis tools and treatments need to be established. A global response should be taken to address a global problem. A global health institution, as the World Health Organization, might be a wise option to quickly recollect and analyze all reported cases, to better understand this new COVID-19 presentation in children. Global data recollection might help establish the correct guidelines to prevent, early detect and effectively treat pediatric-severe-cardiac-cases worldwide.

Clinical characteristics of coronavirus disease 2019 in China

Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Conflict of interest MGL received a grant, from the Spanish Association of Pediatrics to collaborate with TEM on pediatric research at the Division of General Academic Pediatrics, Massachusetts General Hospital for Children, Boston, MA during 2018-19.